Documents & Downloads

Xerophilusin B

Anticancer Agent

Xerophilusin B is an anticancer agent derived from Isodon xerophilus, primarily targeting esophageal squamous cell carcinoma (ESCC). This compound demonstrates significant antiproliferative effects by inducing G2/M cell cycle arrest and promoting apoptosis in cancer cell lines. Its biological activity makes it a valuable tool for research in cancer biology and therapeutic development.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	167894-15-7
Applications	Anticancer Agent
Formula	C₂₀H₂₆O₅
Molecular Weight	346.42
SMILES	O[C@]12[C@]34[C@]5([H])[C@@]6(C(O[C@@]3([H])[C@](CC5)([H])C(C4=O)=C)([H])O2)[C@](C(C)(CCC6)C)([H])[C@@H]1O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.